These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36047192)

  • 1. Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.
    Sasaki Y; Tatsuoka H; Tsuda M; Sumi T; Eguchi Y; So K; Higuchi Y; Takayama K; Torisawa Y; Yamashita F
    Biol Pharm Bull; 2022; 45(9):1246-1253. PubMed ID: 36047192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic Gut-liver chip for reproducing the first pass metabolism.
    Choe A; Ha SK; Choi I; Choi N; Sung JH
    Biomed Microdevices; 2017 Mar; 19(1):4. PubMed ID: 28074384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies.
    Tan HY; Trier S; Rahbek UL; Dufva M; Kutter JP; Andresen TL
    PLoS One; 2018; 13(5):e0197101. PubMed ID: 29746551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic gut-on-a-chip with three-dimensional villi structure.
    Shim KY; Lee D; Han J; Nguyen NT; Park S; Sung JH
    Biomed Microdevices; 2017 Jun; 19(2):37. PubMed ID: 28451924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.
    Gleeson JP; Zhang SY; Subelzu N; Ling J; Nissley B; Ong W; Nofsinger R; Kesisoglou F
    Mol Pharm; 2024 Aug; 21(8):3880-3888. PubMed ID: 38941485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
    Zhang SY; Ong WSY; Subelzu N; Gleeson JP
    Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of rhynchophylline across human intestinal cell in vitro.
    Ma B; Wang J; Sun J; Li M; Xu H; Sun G; Sun X
    Int J Clin Exp Pathol; 2014; 7(5):1957-66. PubMed ID: 24966905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models.
    Kulthong K; Duivenvoorde L; Sun H; Confederat S; Wu J; Spenkelink B; de Haan L; Marin V; van der Zande M; Bouwmeester H
    Toxicol In Vitro; 2020 Jun; 65():104815. PubMed ID: 32119998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology.
    Sakharov D; Maltseva D; Knyazev E; Nikulin S; Poloznikov A; Shilin S; Baranova A; Tsypina I; Tonevitsky A
    BMC Syst Biol; 2019 Mar; 13(Suppl 1):19. PubMed ID: 30836980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment.
    Igarashi F; Nakagawa T; Shinohara Y; Tachibana T
    Pharm Res; 2021 Jun; 38(6):1031-1039. PubMed ID: 34009624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.
    J Vis Exp; 2019 May; (147):. PubMed ID: 31067212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers.
    Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
    Drug Metab Dispos; 2020 Jun; 48(6):491-498. PubMed ID: 32193356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic investigation of the effect of the fluid shear stress on Caco-2 cells towards the optimization of epithelial organ-on-chip models.
    Delon LC; Guo Z; Oszmiana A; Chien CC; Gibson R; Prestidge C; Thierry B
    Biomaterials; 2019 Dec; 225():119521. PubMed ID: 31600674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microfluidic cell culture device (μFCCD) to culture epithelial cells with physiological and morphological properties that mimic those of the human intestine.
    Chi M; Yi B; Oh S; Park DJ; Sung JH; Park S
    Biomed Microdevices; 2015; 17(3):9966. PubMed ID: 26002774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X; Whitfield LR; Stewart BH
    Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
    Liang E; Proudfoot J; Yazdanian M
    Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic in vitro intestinal barrier model coupled to chip-based liquid chromatography mass spectrometry for oral bioavailability studies.
    Santbergen MJC; van der Zande M; Gerssen A; Bouwmeester H; Nielen MWF
    Anal Bioanal Chem; 2020 Feb; 412(5):1111-1122. PubMed ID: 31865418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive measurement of P-glycoprotein-mediated transport activity in Caco-2 cells.
    Wakuda H; Nejime N; Tada Y; Kagota S; Umegaki K; Yamada S; Shinozuka K
    Biol Pharm Bull; 2010; 33(7):1238-41. PubMed ID: 20606320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.